Literature DB >> 32160645

Whole Blood for Civilian Urban Trauma Resuscitation: Historical, Present, and Future Considerations.

Mark Walsh1,2,3, Dietmar Fries4, Ernest Moore5, Hunter Moore5, Scott Thomas3, Hau C Kwaan6, Mathew K Marsee7, Anne Grisoli7, Ross McCauley7, Stefani Vande Lune7, Swetha Chitta3, Sudhir Vyakaranam1,2, Dan Waxman8, Michael T McCurdy9, Donald Zimmer3, Bhavesh Patel10, Jecko Thachil11.   

Abstract

Whole blood (WB) has been used for more than a century for far-forward combat resuscitation. Following the Iraq/Afghanistan combat, maritime, and austere environment use of WB for the resuscitation of severely hemorrhaging patients, there has been an increasing use of WB for the civilian urban resuscitation environment population. The impetus for this was not just improved outcomes in far-forward hospitals, which had different populations and different needs than the civilian urban population, but also an application of the lessons suggested by recent 1:1:1 plasma:platelets:packed red cells fixed-ratio studies for patients with massive transfusion needs. Mechanistic, logistic, and standardization concerns have been addressed and are evolving as the WB project advances. A small number of studies have been published on WB in the civilian urban trauma population. In addition, European experience with viscoelastic testing and resuscitation with fibrinogen and prothrombin complex concentrate has provided another viewpoint regarding the choice of resuscitation strategies for severely bleeding trauma patients in urban civilian environments. There are randomized controlled trials in process, which are testing the hypothesis that WB may be beneficial for the civilian urban population. Whether WB will improve mortality significantly is now a matter of intense study, and this commentary reviews the history, mechanistic foundations, and logistical aspects for the use of WB in the civilian trauma population. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Year:  2020        PMID: 32160645     DOI: 10.1055/s-0040-1702174

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  3 in total

1.  The Role of Fibrinolytic System in Health and Disease.

Authors:  Hau C Kwaan
Journal:  Int J Mol Sci       Date:  2022-05-09       Impact factor: 6.208

Review 2.  Whole Blood, Fixed Ratio, or Goal-Directed Blood Component Therapy for the Initial Resuscitation of Severely Hemorrhaging Trauma Patients: A Narrative Review.

Authors:  Mark Walsh; Ernest E Moore; Hunter B Moore; Scott Thomas; Hau C Kwaan; Jacob Speybroeck; Mathew Marsee; Connor M Bunch; John Stillson; Anthony V Thomas; Annie Grisoli; John Aversa; Daniel Fulkerson; Stefani Vande Lune; Lucas Sjeklocha; Quincy K Tran
Journal:  J Clin Med       Date:  2021-01-17       Impact factor: 4.241

3.  The Hypercoagulable Profile of Patients with Bone Tumors: A Pilot Observational Study Using Rotational Thromboelastometry.

Authors:  Andreas G Tsantes; Ilectra Loukopoulou; Dimitrios V Papadopoulos; Ioannis G Trikoupis; Anastasios G Roustemis; Stavros Goumenos; Rozeta Sokou; Konstantina A Tsante; Anastasios G Kriebardis; Panagiotis Koulouvaris; Dimitra Houhoula; Daniele Piovani; Panayiotis J Papagelopoulos; Stefanos Bonovas; Argirios E Tsantes
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.